The Central Role of Spectroscopy in Fighting Back the Opioid Crisis: Pushing the Limits of Detection of Fentanyl Analogues

The overarching goal of this project is to develop optimized instrumentation and methods for the detection of potent drugs such as fentanyl. SCATR Inc. is a company that develops hardware and software innovative solutions for drug checking with the goal to reduce the harm caused by the use of unknown substances. The collaboration between SCATR and the nanophotonics research laboratory led Dr Lagugne will enables news approaches in particular to detect low amounts of very potent drugs contained in multicomponent mixtures. In particular, the detection of fentanyl analogues will be targeted thus improving of capacity to rapidly detect and quantify this very dangerous substance that causes over 7,500 lethal overdoses per year in Canada.

Faculty Supervisor:

François Lagugné-Labarthet

Student:

Partner:

Scatr

Discipline:

Physics

Sector:

Manufacturing

University:

The University of Western Ontario

Program: